Literature DB >> 2492266

Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity.

K Kagaya1, K Watanabe, Y Fukazawa.   

Abstract

The ability of recombinant gamma interferon (rIFN-gamma) to activate macrophages for Salmonella-killing activity was kinetically examined in relation to phagosome-lysosome fusion and H2O2 generation. Resident peritoneal macrophages of BALB/c mice incubated with 10(2) to 10(3) U of rIFN-gamma per ml for 12 h exhibited enhanced bactericidal activity against Salmonella typhimurium, although H2O2 generation was unaltered. In contrast, macrophages incubated with equal doses of rIFN-gamma for 48 h showed both an enhanced Salmonella-killing activity and an increased generation of H2O2. To evaluate Salmonella-killing activities of macrophages, intracellular bacteria were assayed at 0, 2, and 8 h after infection. During the initial 2 h of infection, 12-h-activated macrophages, as well as the unstimulated control macrophages, showed a decline in bacterial population at the same rate. Over the next 6 h of infection, however, the number of viable bacteria in activated macrophages remained unchanged, whereas the number of bacteria in control macrophages significantly (P less than 0.05) increased. Similar results were obtained in 48-h-activated macrophages. On the other hand, macrophages incubated with 10 to 10(3) U of rIFN-gamma exhibited enhanced fusion of lysosomes to Salmonella-containing phagosomes in both the 12-h- and 48-h-stimulated stages. Moreover, when 48-h-activated macrophages were incubated concomitantly with superoxide dismutase and catalase, Salmonella-killing activity was not affected. These results indicate that rIFN-gamma per se is able to activate peritoneal macrophages to induce Salmonella-killing activity and suggest that increased phagosome-lysosome fusion followed by an oxygen-independent killing mechanism is primarily responsible for the enhanced Salmonella-killing activity in rIFN-gamma-activated macrophages.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492266      PMCID: PMC313140          DOI: 10.1128/iai.57.2.609-615.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.

Authors:  R D Schreiber; L J Hicks; A Celada; N A Buchmeier; P W Gray
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

2.  Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages.

Authors:  C D Rothermel; B Y Rubin; E A Jaffe; H W Murray
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

3.  A lymphokine distinct from interferon-gamma that activates human monocytes to kill Leishmania donovani in vitro.

Authors:  D L Hoover; D S Finbloom; R M Crawford; C A Nacy; M Gilbreath; M S Meltzer
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

4.  Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.

Authors:  J C Lee; L Rebar; P Young; F W Ruscetti; N Hanna; G Poste
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

5.  Delayed-type hypersensitivity and immunity to Salmonella typhimurium.

Authors:  L M Killar; T K Eisenstein
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

6.  Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi.

Authors:  E Brummer; C J Morrison; D A Stevens
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

7.  Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.

Authors:  H W Murray; G L Spitalny; C F Nathan
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

8.  Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection.

Authors:  T K Eisenstein; L M Killar; B M Sultzer
Journal:  J Infect Dis       Date:  1984-09       Impact factor: 5.226

9.  Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes.

Authors:  J A Armstrong; P D Hart
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

10.  Oxygen-independent killing by alveolar macrophages.

Authors:  J R Catterall; S D Sharma; J S Remington
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

View more
  53 in total

1.  Identification of genes required for chronic persistence of Brucella abortus in mice.

Authors:  P C Hong; R M Tsolis; T A Ficht
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Inhibition of macrophage phagosome-lysosome fusion by Salmonella typhimurium.

Authors:  N A Buchmeier; F Heffron
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

3.  Assessment of the correlation between nitrite concentration and listericidal activity in cultures of resident and elicited murine macrophages.

Authors:  J N Higginbotham; S B Pruett
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

4.  Murine osteoblasts respond to LPS and IFN-gamma similarly to macrophages.

Authors:  Kenta Maruyama; Gen-Ichiro Sano; Koichi Matsuo
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

5.  Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium: persistence and immune response in BALB/c mice and susceptibility to macrophage killing.

Authors:  K Denich; P Börlin; P D O'Hanley; M Howard; A W Heath
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

6.  Role of gamma interferon in late stages of murine salmonellosis.

Authors:  A Muotiala; P H Mäkelä
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

7.  Early interferon-γ production in human lymphocyte subsets in response to nontyphoidal Salmonella demonstrates inherent capacity in innate cells.

Authors:  Tonney S Nyirenda; Anna E Seeley; Wilson L Mandala; Mark T Drayson; Calman A MacLennan
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

8.  Inhibition of Ehrlichia risticii infection in murine peritoneal macrophages by gamma interferon, a calcium ionophore, and concanavalin A.

Authors:  J Park; Y Rikihisa
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

9.  Intracellular adhesion molecule 1 plays a key role in acquired immunity to salmonellosis.

Authors:  Simon Clare; Robert Goldin; Christine Hale; Richard Aspinall; Cameron Simmons; Pietro Mastroeni; Gordon Dougan
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Implication of phagosome-lysosome fusion in restriction of Mycobacterium avium growth in bone marrow macrophages from genetically resistant mice.

Authors:  C de Chastellier; C Fréhel; C Offredo; E Skamene
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.